-
Your next patient is a young woman who was in two months ago for a chlamydia infection. You provided her with a prescription and asked that she have her partner come in for evaluation, testing, and treatment.
-
What is your practice when it comes to screening women for chlamydia? The Centers for Disease Control and Prevention (CDC) recommends annual chlamydia screening for all sexually active young women age 25 and younger.
-
While it is not in the top tier of contraceptive effectiveness, the diaphragm remains an option as a female-controlled method of birth control. What do you know about this form of family planning?
-
Many women might choose the contraceptive injection depot medroxyprogesterone acetate (DMPA, Depo-Provera) for its ease of use, but they might discontinue the method due to irregular bleeding.
-
Findings from a new national report reflect an increase in the use of early medication abortion.
-
While the human papillomavirus (HPV) vaccine has been approved for use in men, how many are open to receiving it? New research indicates men might be more willing to receive vaccination when they learn the vaccine can prevent cancer.
-
-
Do Topical Steroids Lead to Glaucoma or Cataract?; Can Exenatide Prevent Glucocorticoid-Induced Hyperglycemia?; COPD: Beyond Pulmocentricity; Aspirin and Risk of Death from Cancer; Reducing Incontinence After Prostatectomy; Real-life Efficacy of Herpes Zoster Vaccine
-
-
In this study, 783 HIV-infected Indian mother-infant pairs participated in a randomized clinical trial comparing NVP given for 6 weeks vs. single-dose NVP to prevent MTCT of HIV among breast-fed infants.
